Bamethan

Last updated
Bamethan
Bamethan.png
Clinical data
AHFS/Drugs.com International Drug Names
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
Identifiers
  • 1-(p-hydroxyphenol)-2-butylamino-1-ethanol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.020.949 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C12H19NO2
Molar mass 209.289 g·mol−1
3D model (JSmol)
  • OC(c1ccc(O)cc1)CNCCCC
  • InChI=1S/C12H19NO2/c1-2-3-8-13-9-12(15)10-4-6-11(14)7-5-10/h4-7,12-15H,2-3,8-9H2,1H3 Yes check.svgY
  • Key:RDUHXGIIUDVSHR-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Bamethan is a vasodilator. [1] :94

Related Research Articles

<span class="mw-page-title-main">Pharmacology</span> Branch of biology concerning drugs

Pharmacology is a branch of medicine, biology, and pharmaceutical sciences concerned with drug or medication action, where a drug may be defined as any artificial, natural, or endogenous molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism. It is the science of drugs including their origin, composition, pharmacokinetics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.

<i>British National Formulary</i> Pharmaceutical reference book for the UK

The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS). Information within the BNF includes indication(s), contraindications, side effects, doses, legal classification, names and prices of available proprietary and generic formulations, and any other notable points. Though it is a national formulary, it nevertheless also includes entries for some medicines which are not available under the NHS, and must be prescribed and/or purchased privately. A symbol clearly denotes such drugs in their entry.

<span class="mw-page-title-main">Medication</span> Substance used to diagnose, cure, treat, or prevent disease

A medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist, also known as a chemist or a druggist, is a healthcare professional who dispenses medications and who provides advice on their safe use, with the aim of preventing disease and promoting public health. Pharmacists often serve as primary care providers in the community, and may offer other services such as health screenings and immunizations.

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">Pharmacopoeia</span> Book containing directions for the identification of compound medicines

A pharmacopoeia, pharmacopeia, or pharmacopoea, in its modern technical sense, is a book containing directions for the identification of compound medicines, and published by the authority of a government or a medical or pharmaceutical society.

The Royal Pharmaceutical Society of Great Britain (RPSGB) existed from its founding as the Pharmaceutical Society of Great Britain in 1841 until 2010. The word "Royal" was added to its name in 1988. It was the statutory regulatory and professional body for pharmacists and pharmacy technicians in England, Scotland and Wales. In September 2010, the regulatory powers of the Society were transferred to the newly formed General Pharmaceutical Council (GPhC). The RPSGB became the Royal Pharmaceutical Society (RPS) at that time and retained its professional leadership role; the "Great Britain" part of the name was dropped for day-to-day purposes.

The Royal Pharmaceutical Society is the body responsible for the leadership and support of the pharmacy profession (pharmacists) within England, Scotland, and Wales. It was created along with the General Pharmaceutical Council (GPhC) in September 2010 when the previous Royal Pharmaceutical Society of Great Britain was split so that representative and regulatory functions of the pharmacy profession could be separated. Membership in the society is not a prerequisite for engaging in practice as a pharmacist within the United Kingdom. Its predecessor the Pharmaceutical Society of Great Britain was founded on 15 April 1841.

The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom. It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

<span class="mw-page-title-main">Association of the British Pharmaceutical Industry</span>

The Association of the British Pharmaceutical Industry (ABPI) is the trade association for over 120 companies in the UK producing prescription medicines for humans, founded in 1891. It is the British equivalent of America's PhRMA; however, the member companies research, develop, manufacture and supply 80% of the medicines prescribed through the National Health Service.

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

The Pharmaceutical Journal is a professional journal covering various aspects of pharmacy, including pharmacology and pharmaceutics. It is published by, and is the official journal of, Britain's professional organisation for pharmacists, the Royal Pharmaceutical Society.

<span class="mw-page-title-main">Iloperidone</span> Chemical compound

Iloperidone, commonly known as Fanapt and previously known as Zomaril, is an atypical antipsychotic for the treatment of schizophrenia.

The British Pharmaceutical Codex (BPC) was first published in 1907, to supplement the British Pharmacopoeia which although extensive, did not cover all the medicinal items that a pharmacist might require in daily work. Other books existed, such as Squire's, but the BPC was intended to be official, published by the Pharmaceutical Society of Great Britain (PSGB). It laid down standards for the composition of medicines and surgical dressings.

<span class="mw-page-title-main">Allen & Hanburys</span> British pharmaceutical manufacturer

Allen and Hanburys Ltd was a British pharmaceutical manufacturer, absorbed by Glaxo Laboratories in 1958. GlaxoSmithKline, its successor company, used the Allen and Hanburys name for the specialist respiratory division until beginning to phase it out in 2013. In 2021, the name was trademarked in the United States as part of the formation of Allen & Hanburys Inc., an American pharmaceutical and consumer products company focused on Pediatrics, Dermatology and Respiratory Care exclusively within the United States.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

The Faculty of Pharmaceutical Medicine (FPM) is a faculty of the three Royal Colleges of Physicians of the United Kingdom. It is a UK-based professional membership organisation with 1,600 members; physicians with a professional interest in the speciality of pharmaceutical medicine, the science of discovering, developing and testing new drugs, their regulation, and monitoring them for safety both during development and when they are prescribed. FPM is a registered charity and ultimately exists to bring about an improvement in health in patients and the general population.

Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs. In the majority of circumstances, drugs have 3 types of names: chemical names, the most important of which is the IUPAC name; generic or nonproprietary names, the most important of which are international nonproprietary names (INNs); and trade names, which are brand names. Under the INN system, generic names for drugs are constructed out of affixes and stems that classify the drugs into useful categories while keeping related names distinguishable. A marketed drug might also have a company code or compound code.

<span class="mw-page-title-main">Prednisolamate</span> Chemical compound

Prednisolamate, also known as prednisolone 21-diethylaminoacetate, is a synthetic corticosteroid. It is or was a component of Etaproctene, which contains lidocaine, prednisolamate hydrochloride, and tetryzoline.

<span class="mw-page-title-main">Triamcinolone aminobenzal benzamidoisobutyrate</span> Chemical compound

Triamcinolone aminobenzal benzamidoisobutyrate is a synthetic glucocorticoid corticosteroid which is no longer marketed.

References

  1. British Medical Association, Pharmaceutical Society of Great Britain. (1987). British National Formulary. Vol. 11. Pharmaceutical Press. ISBN   978-0-85369-191-4.